Expression of Endoglin mRNA and Protein in Human Vascular Smooth Muscle Cells
- 9 June 1998
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 247 (1) , 33-37
- https://doi.org/10.1006/bbrc.1998.8734
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.Journal of Clinical Investigation, 1997
- Endoglin modulates cellular responses to TGF-beta 1.The Journal of cell biology, 1996
- Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin?Journal of Medical Genetics, 1996
- Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1Nature Genetics, 1994
- Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) miceNature, 1994
- Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model.Journal of Clinical Investigation, 1994
- Assignment of the human endoglin gene (END) to 9q34→qterCytogenetic and Genome Research, 1993
- Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.Journal of Clinical Investigation, 1992
- Production of transforming growth factor beta 1 during repair of arterial injury.Journal of Clinical Investigation, 1991
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986